The global prothrombin complex concentrates market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing incidence of thrombotic disorders and the rising demand for prophylactic treatment in patients with high risk of developing thrombotic disorders. 3F Prothrombin Complex Concentrates are expected to account for a significant share in the global prothrombin complex concentrates market during the forecast period, owing to their higher efficacy and lower cost as compared with 4F Prothrombin Complex Concentrates. 3F Prothrombin Complex Concentrates are also preferred by hospitals due to their longer shelf life as compared with 4F Prothrombin Complex Concentrates. Compound pharmacies accounted for a significant share in the global prothrombin complex concentrates market in 2018, owing to their wide distribution network and low prices as compared with hospital pharmacies.
Some Of The Growth Factors Of This Market:
- Increasing incidence of cardiovascular diseases and increasing awareness about the benefits of Prothrombin Complex Concentrates are some factors that are driving the growth of this market.
- Increasing prevalence of chronic kidney disease and increasing number of patients with acute coronary syndrome are some factors that will drive the growth in this market during the forecast period, 2018-2025.
- Increasing number of new product launches by key players in this industry is one factor that will drive the growth in this market.
Industry Growth Insights published a new data on “Prothrombin Complex Concentrates Market”. The research report is titled “Prothrombin Complex Concentrates Market research by Types (3F Prothrombin Complex Concentrates, 4F Prothrombin Complex Concentrates), By Applications (Compound Pharmacies, Hospital Pharmacies, Retail Pharmacies), By Players/Companies Shire, Octapharma AG, Nihon Pharmaceutical, Sanquin Blood Supply Foundation, CSL Behring GmbH, Grifols”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Prothrombin Complex Concentrates Market Research Report
By Type
3F Prothrombin Complex Concentrates, 4F Prothrombin Complex Concentrates
By Application
Compound Pharmacies, Hospital Pharmacies, Retail Pharmacies
By Companies
Shire, Octapharma AG, Nihon Pharmaceutical, Sanquin Blood Supply Foundation, CSL Behring GmbH, Grifols
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Prothrombin Complex Concentrates Market Report Segments:
The global Prothrombin Complex Concentrates market is segmented on the basis of:
Types
3F Prothrombin Complex Concentrates, 4F Prothrombin Complex Concentrates
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Compound Pharmacies, Hospital Pharmacies, Retail Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shire
- Octapharma AG
- Nihon Pharmaceutical
- Sanquin Blood Supply Foundation
- CSL Behring GmbH
- Grifols
Highlights of The Prothrombin Complex Concentrates Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 3F Prothrombin Complex Concentrates
- 4F Prothrombin Complex Concentrates
- By Application:
- Compound Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prothrombin Complex Concentrates Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Prothrombin complex concentrates are a type of blood product that helps to prevent blood clots.
Some of the key players operating in the prothrombin complex concentrates market are Shire, Octapharma AG, Nihon Pharmaceutical, Sanquin Blood Supply Foundation, CSL Behring GmbH, Grifols.
The prothrombin complex concentrates market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Prothrombin Complex Concentrates Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Prothrombin Complex Concentrates Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Prothrombin Complex Concentrates Market - Supply Chain
4.5. Global Prothrombin Complex Concentrates Market Forecast
4.5.1. Prothrombin Complex Concentrates Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Prothrombin Complex Concentrates Market Size (000 Units) and Y-o-Y Growth
4.5.3. Prothrombin Complex Concentrates Market Absolute $ Opportunity
5. Global Prothrombin Complex Concentrates Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Prothrombin Complex Concentrates Market Size and Volume Forecast by Type
5.3.1. 3F Prothrombin Complex Concentrates
5.3.2. 4F Prothrombin Complex Concentrates
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Prothrombin Complex Concentrates Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Prothrombin Complex Concentrates Market Size and Volume Forecast by Application
6.3.1. Compound Pharmacies
6.3.2. Hospital Pharmacies
6.3.3. Retail Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Prothrombin Complex Concentrates Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Prothrombin Complex Concentrates Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Prothrombin Complex Concentrates Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Prothrombin Complex Concentrates Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Prothrombin Complex Concentrates Demand Share Forecast, 2019-2026
9. North America Prothrombin Complex Concentrates Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Prothrombin Complex Concentrates Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Prothrombin Complex Concentrates Market Size and Volume Forecast by Application
9.4.1. Compound Pharmacies
9.4.2. Hospital Pharmacies
9.4.3. Retail Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Prothrombin Complex Concentrates Market Size and Volume Forecast by Type
9.7.1. 3F Prothrombin Complex Concentrates
9.7.2. 4F Prothrombin Complex Concentrates
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Prothrombin Complex Concentrates Demand Share Forecast, 2019-2026
10. Latin America Prothrombin Complex Concentrates Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Prothrombin Complex Concentrates Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Prothrombin Complex Concentrates Market Size and Volume Forecast by Application
10.4.1. Compound Pharmacies
10.4.2. Hospital Pharmacies
10.4.3. Retail Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Prothrombin Complex Concentrates Market Size and Volume Forecast by Type
10.7.1. 3F Prothrombin Complex Concentrates
10.7.2. 4F Prothrombin Complex Concentrates
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Prothrombin Complex Concentrates Demand Share Forecast, 2019-2026
11. Europe Prothrombin Complex Concentrates Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Prothrombin Complex Concentrates Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Prothrombin Complex Concentrates Market Size and Volume Forecast by Application
11.4.1. Compound Pharmacies
11.4.2. Hospital Pharmacies
11.4.3. Retail Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Prothrombin Complex Concentrates Market Size and Volume Forecast by Type
11.7.1. 3F Prothrombin Complex Concentrates
11.7.2. 4F Prothrombin Complex Concentrates
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Prothrombin Complex Concentrates Demand Share, 2019-2026
12. Asia Pacific Prothrombin Complex Concentrates Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Prothrombin Complex Concentrates Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Prothrombin Complex Concentrates Market Size and Volume Forecast by Application
12.4.1. Compound Pharmacies
12.4.2. Hospital Pharmacies
12.4.3. Retail Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Prothrombin Complex Concentrates Market Size and Volume Forecast by Type
12.7.1. 3F Prothrombin Complex Concentrates
12.7.2. 4F Prothrombin Complex Concentrates
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Prothrombin Complex Concentrates Demand Share, 2019-2026
13. Middle East & Africa Prothrombin Complex Concentrates Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Prothrombin Complex Concentrates Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Prothrombin Complex Concentrates Market Size and Volume Forecast by Application
13.4.1. Compound Pharmacies
13.4.2. Hospital Pharmacies
13.4.3. Retail Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Prothrombin Complex Concentrates Market Size and Volume Forecast by Type
13.7.1. 3F Prothrombin Complex Concentrates
13.7.2. 4F Prothrombin Complex Concentrates
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Prothrombin Complex Concentrates Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Prothrombin Complex Concentrates Market: Market Share Analysis
14.2. Prothrombin Complex Concentrates Distributors and Customers
14.3. Prothrombin Complex Concentrates Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Shire
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Octapharma AG
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nihon Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sanquin Blood Supply Foundation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. CSL Behring GmbH
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Grifols
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook